Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DSEA campaign ready

This article was originally published in The Tan Sheet

Executive Summary

The Dietary Supplement Education Alliance purchases ad time in TV talk and game shows, prime time dramas and other broadcasts for the test run of its "Just Like Me" campaign starting in October, DSEA says Aug. 29. In a memo to DSEA board members, campaign manager Elliott Balbert says 30- or 60-second ads will air on national network affiliates more than 1,600 times over six weeks in the three test markets, Hartford/New Haven, Conn., Jacksonville, Fla., and Green Bay, Wis. The TV ads direct consumers to 1www.justlikeme.org to redeem more than $130 in vitamin discount coupons. DSEA says 15 magazines have agreed to run at least one full-page ad on a complimentary basis, and bonus offers for consumers from more than 20 companies will run in some health magazines. Balbert says the campaign, which DSEA announced in February to improve the industry's image, will deliver as many as 40 million advertising impressions and a list of up to 1 million potential customers (2"The Tan Sheet" Feb. 12, 2007, p. 17)...

You may also be interested in...



Media Campaign May Bloom In Spring, DSEA Says; Leiner, NOW Show Support

The Dietary Supplement Education Alliance unveiled the prototype of its Just Like Me paid-media campaign at the Focus on the Future conference in Scottsdale, Ariz., Feb. 1

Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company

The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.

Synthekine Joins Quest To Tame IL-2 In Cancer Therapies

First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100907

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel